Equities research analysts predict that HB Fuller Co (NYSE:FUL) will announce $802.90 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for HB Fuller’s earnings, with the lowest sales estimate coming in at $793.60 million and the highest estimate coming in at $818.00 million. HB Fuller posted sales of $678.20 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 18.4%. The firm is expected to issue its next earnings results on Tuesday, January 22nd.
According to Zacks, analysts expect that HB Fuller will report full year sales of $3.09 billion for the current financial year, with estimates ranging from $3.07 billion to $3.13 billion. For the next year, analysts anticipate that the firm will post sales of $3.20 billion, with estimates ranging from $3.14 billion to $3.30 billion. Zacks’ sales calculations are a mean average based on a survey of research firms that follow HB Fuller.
HB Fuller (NYSE:FUL) last announced its quarterly earnings results on Wednesday, September 26th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.04). The company had revenue of $770.11 million during the quarter, compared to analysts’ expectations of $784.75 million. HB Fuller had a net margin of 4.14% and a return on equity of 13.41%.
A number of equities analysts have recently issued reports on FUL shares. Zacks Investment Research upgraded shares of HB Fuller from a “hold” rating to a “buy” rating and set a $65.00 price target for the company in a report on Wednesday, August 29th. Berenberg Bank started coverage on shares of HB Fuller in a report on Thursday, July 12th. They issued a “buy” rating and a $65.00 price target for the company. Deutsche Bank cut their price target on shares of HB Fuller from $62.00 to $60.00 and set a “buy” rating for the company in a report on Friday, September 28th. Robert W. Baird cut their price target on shares of HB Fuller from $60.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, September 28th. Finally, ValuEngine downgraded shares of HB Fuller from a “hold” rating to a “sell” rating in a report on Friday, September 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $61.00.
Shares of FUL traded up $0.40 during trading hours on Friday, reaching $47.62. The company had a trading volume of 5,617 shares, compared to its average volume of 448,987. The company has a quick ratio of 1.48, a current ratio of 2.25 and a debt-to-equity ratio of 2.03. The company has a market capitalization of $2.39 billion, a PE ratio of 19.01, a P/E/G ratio of 0.80 and a beta of 1.46. HB Fuller has a 12-month low of $41.26 and a 12-month high of $59.58.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 1st. Investors of record on Thursday, October 18th were paid a $0.155 dividend. The ex-dividend date of this dividend was Wednesday, October 17th. This represents a $0.62 dividend on an annualized basis and a yield of 1.30%. HB Fuller’s payout ratio is 24.80%.
In related news, VP Traci L. Jensen sold 4,508 shares of the stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $57.45, for a total value of $258,984.60. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 3.46% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the stock. SG Americas Securities LLC grew its stake in HB Fuller by 77.5% in the 2nd quarter. SG Americas Securities LLC now owns 24,360 shares of the specialty chemicals company’s stock valued at $1,308,000 after acquiring an additional 10,633 shares during the last quarter. Schwab Charles Investment Management Inc. grew its stake in HB Fuller by 9.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 398,043 shares of the specialty chemicals company’s stock valued at $21,367,000 after acquiring an additional 33,956 shares during the last quarter. Engineers Gate Manager LP grew its stake in HB Fuller by 106.5% in the 2nd quarter. Engineers Gate Manager LP now owns 46,041 shares of the specialty chemicals company’s stock valued at $2,471,000 after acquiring an additional 23,750 shares during the last quarter. Raymond James & Associates grew its stake in HB Fuller by 4.6% in the 2nd quarter. Raymond James & Associates now owns 108,190 shares of the specialty chemicals company’s stock valued at $5,808,000 after acquiring an additional 4,762 shares during the last quarter. Finally, Wedge Capital Management L L P NC grew its stake in HB Fuller by 12.1% in the 3rd quarter. Wedge Capital Management L L P NC now owns 463,557 shares of the specialty chemicals company’s stock valued at $23,952,000 after acquiring an additional 50,058 shares during the last quarter. 97.65% of the stock is currently owned by hedge funds and other institutional investors.
HB Fuller Company Profile
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.
See Also: What is a capital gain?
Get a free copy of the Zacks research report on HB Fuller (FUL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.